Should a Reduction in All-Cause Mortality Be the Goal When Assessing Preventive Medical Therapies?

Affiliations

¹ From Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. p.sasieni@qmul.ac.uk.
² From Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK.

Peter D Sasieni et al. Circulation. 2017.

. 2017 May 23;135(21):1985-1987.

doi: 10.1161/CIRCULATIONAHA.116.023359.

¹ From Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK. p.sasieni@qmul.ac.uk.
² From Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, UK.

No abstract available

Keywords: all-cause death; cardiovascular disease; cardiovascular events; clinical trial; statistical analysis.

MeSH terms